0001654954-22-015321.txt : 20221114
0001654954-22-015321.hdr.sgml : 20221114
20221114202108
ACCESSION NUMBER: 0001654954-22-015321
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221114
FILED AS OF DATE: 20221114
DATE AS OF CHANGE: 20221114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: lee ting-chuan
CENTRAL INDEX KEY: 0001859311
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41461
FILM NUMBER: 221388869
MAIL ADDRESS:
STREET 1: 8880 RIO SAN DIEGO DRIVE
STREET 2: SUITE 800
CITY: SAN DIEGO
STATE: CA
ZIP: 92108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ainos, Inc.
CENTRAL INDEX KEY: 0001014763
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 751974352
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: AINOS, INC.
STREET 2: 8880 RIO SAN DIEGO DRIVE SUITE 800
CITY: SAN DIEGO
STATE: CA
ZIP: 92108
BUSINESS PHONE: 858-869-2986
MAIL ADDRESS:
STREET 1: AINOS, INC.
STREET 2: 8880 RIO SAN DIEGO DRIVE SUITE 800
CITY: SAN DIEGO
STATE: CA
ZIP: 92108
FORMER COMPANY:
FORMER CONFORMED NAME: AMARILLO BIOSCIENCES INC
DATE OF NAME CHANGE: 19960516
4
1
section16.xml
PRIMARY DOCUMENT
X0306
4
2022-11-14
0001014763
Ainos, Inc.
AIMD
0001859311
lee ting-chuan
8880 RIO SAN DIEGO DRIVE, SUITE 800
SAN DIEGO
CA
92108
true
RSU
2022-11-14
4
A
false
70000
A
Common Stock
70000
70000
D
Reference is made to the RSUs granted under the 2021 Stock Incentive Plan. Each RSU represents a right to receive one (1) share of common stock upon vesting and the expiration of any applicable restricted period or, if approved, the cash value thereof (or any combination thereof). Holders of RSUs have no rights or privileges as a stockholder. Except as otherwise agreed, if the Reporting Person's participation is terminated for any reason prior to the date that all of its RSU have vested, all vesting rights shall cease and all unvested RSU shall be forfeited for no consideration as of the date termination. Vesting dates related to the 70,000 RSUs are as follows: 10,500 shares on 5/14/23 and 11/14/23, respectively, 21,000 shares on 11/14/24 and 28,000 shares on 11/14/25.
/s/ Ting-Chuan Lee, Director
2022-11-14